Using lived experience of pancreatic cancer to build faith-based support

Adjuvant pembrolizumab fails to improve recurrence-free survival after curative therapy in hepatocellular carcinoma

Talquetamab plus teclistamab shows promise in true extramedullary multiple myeloma

Precision approaches to treating HPB cancers

MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection

The hidden biology of addiction and cancer

Durvalumab and tremelimumab show manageable safety in poor-prognosis HCC

Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancer

Tumor Treating Fields plus chemo shows OS benefit in unresectable pancreatic cancer

Characteristics associated with longer-term OS with NALIRIFOX regimen in metastatic pancreatic adenocarcinoma

Gemcitabine/nab-paclitaxel compared with 5-fluorouracil/leucovorin/liposomal irinotecan shows similar results in older patients

Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study